Prostate Cancer CME Series: Primary Care Clinical Case Scenarios

Monday, August 1, 2022, 12:00 AM - Thursday, July 31, 2025, 11:59 PM, On Demand

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine.

Apply your knowledge and practice skills by examining five clinical case scenarios. This interactive learning module targets primary care clinicians who manage prostate cancer patients across the continuum of care. Each clinical case scenario allows you to work through history taking, investigations, differential diagnosis, and management. Using an interactive electronic health record (EHR) format, learners will explore early detection and intervention strategies for prostate cancer.

  Release Date: August 1, 2022
  Expiration Date: July 31, 2025
  Estimated Time to Complete: ~15 minutes
  Registration Fee: FREE 


AMA PRA Category 1 Credits™ (0.25 hours), Non-Physician Participation Credit (0.25 hours)

1. Recommend interventions and a treatment plan based on history, risk factors, and staging in the castration-sensitive prostate cancer (CSPC) setting.
2. Develop assessment and monitoring skills in patients in the early stages of prostate cancer.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.American Cancer Society. (2021, April 23). American Cancer Society Recommendations for Prostate Cancer Early Detection. Retrieved July 19, 2022. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html.
2.Urology Care Foundation. (2021, Sept). Benign Prostatic Hyperplasia (BPH). Retrieved July 19, 2022. https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph).
3.Egerdie, B., & Saad, F. (2010). Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 4(2), 129–135. https://doi.org/10.5489/cuaj.811
4.Kotwal, A., Mohile, S., Dale, W. (2012, March 5). Remaining Life Expectancy Measurement and PSA Screening of Older Men. Journal of Geriatric Oncology 3, 3: 196–204. https://doi.org/10.1016/j.jgo.2012.02.003.
5.Lerner, L.B., McVary, K.T., Barry, M.J., al. (2021, Oct 1) Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management. Journal of Urology 206, 4: 806–17. https://doi.org/10.1097/JU.0000000000002183.
6.Barocas, D.A., Boorjian, S.A., Alvarez, R.D., et al. (2020, Oct). Microhematuria: AUA/SUFU guideline. Journal of Urology 204: 778.
7.Park, H.J., Won, J.E., Sorsaburu, S., Rivera, P.D., Lee, S.W.  (2013, Dec)  Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.  The World Journal of Men’s Health 31(3):193-207.   https://doi.org/10.5534/wjmh.2013.31.3.193

For activity related questions, please contact
     Name: Emily Manche
     Title: CME Compliance Coordinator
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.